FDA Adverse Event Injury Summary report: N

XTRAC EXCIMER AL10000

MDR report key: 3299647 · Received August 15, 2013

Report

Report Number
2031934-2013-00001
Event Type
Injury
Date Received
August 15, 2013
Date of Event
May 22, 2013
Report Date
August 14, 2013
Manufacturer
PHOTO MEDEX, INC.
Product Code
GEX
PMA / PMN Number
K073659
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

BURNING IS A NORMAL OUTCOME OF TREATMENT WITH UVB THERAPY, AND IS ACTUALLY INDICATIVE OF SUCCESSFUL TREATMENT. HOWEVER, BURNS CAUSING OPEN WOUNDS ARE NOT CONSIDERED NORMAL. A COMPANY REPRESENTATIVE FOLLOWED-UP WITH THE PATIENT, AND CONFIRMED THE INITIAL REPORTED INFORMATION AND CONFIRMED THAT THE PATIENT HAD HEALED FROM HER BURNS. A COMPANY REPRESENTATIVE ALSO SPOKE TO THE TREATING FACILITY AND CONFIRMED THE DEVICE IN QUESTION AND THE TREATMENT PARAMETERS. THE TREATMENT PARAMETERS WERE NORMAL PER THE TREATMENT PROTOCOL. ADDITIONALLY, A FIELD SERVICE REPRESENTATIVE EVALUATED THE DEVICE AT THE TREATING FACILITY, AND DETERMINED IT WAS OPERATING WITHIN SPECIFICATION. WE DO NOT BELIEVE THE DEVICE MALFUNCTIONED TO CAUSE THIS ADVERSE REACTION; IT REMAINS UNCLEAR WHY THE PATIENT BURNED SEVERELY ENOUGH TO REQUIRE MEDICAL TREATMENT. AS STATED ABOVE, BURNING IS NORMAL AN ALL PATIENTS REACT DIFFERENTLY TO UVB EXPOSURE. UPON INITIAL REVIEW OF THE COMPLAINTS DETAILS, IT DID NOT APPEAR TO BE A REPORTABLE INCIDENT. AFTER FURTHER REVIEW AND DISCUSSION, PHOTOMEDEX LATER DETERMINED IT WAS NECESSARY TO REPORT THIS INCIDENT. THIS EXPLAINS THE TIME LAG IN REPORTING.

Description of Event or Problem · 1

PATIENT TREATED WITH DEVICE, DEVELOPED BURNS ON THE BOTTOM OF HER FEET. PATIENT SOUGHT MEDICAL ATTENTION AT AN ED, BURNS ASSESSED TO BE 2ND DEGREE AND TREATED WITH PROPHYLACTIC ANTIBIOTICS AND SILVADENE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
393532 XTRAC EXCIMER AL10000 EXCIMER LASER SYSTEM GEX PHOTO MEDEX, INC. AL10000 NA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention